Clinician's Roundtable

Host: Howard Levy, MD, PhD Guest: David H. Ledbetter, PhD, FACMG From the ASHG Meeting in San Diego, Dr. Howard Levy is joined by Dr. David Ledbetter, Executive Vice President and Chief Scientific Officer at Geisinger Health System. Dr. Ledbetter shares his career story as an internationally recognized researcher in the advancement of medical genomics, and the initiatives he is leading at Geisinger to bring genomic sequencing to primary care settings for improved risk assessments and better patient outcomes.

Host: Prathima Setty, MD Issues of vaginal health are commonly seen in post-menopausal women, breast cancer survivors and women who have had a hysterectomy. According to the US Census Bureau there are nearly 46M women between the ages of 50 and 80, and over 2.8M breast cancer survivors. Existing treatments for post-menopause vaginal health can be time intensive or messy, or contraindicated for health reasons. They also can have numerous side-effects and offer only marginal improvement -- according to a doctor associated with the study. Host Dr. Prathima Setty welcomes Dr. Mickey Karram, Director of Fellowship Program on Female Pelvic Medicine & Reconstructive Surgery at The Christ Hospital, Cincinnati, OH. Dr. Karram will share preliminary findings from a trail evaluating laser treatment on post-menopausal women and breast cancer survivors experiencing vaginal health issues. Supported by an Educational Grant from BD Diagnostics. ReachMD retains full editorial control of the content for this program.

Host: Matt Birnholz, MD There’s an estimated 450,000 people with multiple sclerosis in the United States, and of this staggering number, there are 2 to 3 times as many women as men, with a gender gap that is only widening. Since the majority of women with MS get diagnosed in their 20’s and 30’s, the need for understanding the reproductive impacts of MS becomes critical. How can clinicians address these challenges in practice? Joining Dr. Matt Birnholz at Omnia Education’s Women’s Health Annual Visit in New York is Dr. Carolina Ionete, Associate Professor of Clinical Neurology at the University of Massachusetts, and Associate Director of the MS Center in Wooster, MA.

Host: Ana Maria Rosario Pancreatic Cancer strikes fear into the hearts of every practicing internist, pathologist, oncologist, and general surgeon on behalf of their patients, and unfortunately for us all, it’s on the rise. By 2030 it will be expected to climb to the number-2 spot for causes of cancer death. What new insights can we bring to the recognition and identification of pancreatic cancer to help curb that trend? Joining host Ana Maria Rosario at Omnia Education’s Stages in Women’s Health in New York is Dr. Aimee Lucas, Assistant Professor of Medicine at the Icahn School of Medicine at Mount Sinai in New York.

Host: Matt Birnholz, MD Risk assessments for ovarian tumors are ever-evolving, as advances in diagnostic imaging and biomarker development pave the way. What are the current views on overian tumor risk assessment, and how should they be incorporated into clinical practice? Joining Dr. Matt Birnholz to address these questions is Dr. Fred Ueland, Professor of Obstetrics and Gynecology, and Director of Gynecologic Oncology at the University of Kentucky.

Host: Prathima Setty, MD What are the benefits and harms of screening women for breast cancer? How often should we screen our patients? Are there technological advancements to help our patients live better and longer? Dr. Prathima Setty welcomes Dr. Russell P. Harris, Professor of Medicine and Adjunct Professor of Epidemiology at University of North Carolina, Chapel Hill, NC. Supported by an Educational Grant from BD Diagnostics. ReachMD retains full editorial control of the content for this program.

Host: Prathima Setty, MD Host Dr. Prathima Setty is joined by Dr. Bethanee J Schlosser, Assistant Professor in Dermatology and Obstetrics and Gynecology at Northwestern University Feinberg School of Medicine, Chicago, IL. Dr. Schlosser discusses hair concerns and changes in post menopausal patients. She also addresses the importance of identifying the major causes, treatment options, and goals for patients who are suffering from hair loss of the scalp, increased facial hair and other hair changes. About NAMS The interview was conducted live at The North American Menopause Society (NAMS) 2014 meeting. Founded in 1989, NAMS is North America's leading nonprofit organization dedicated to promoting the health and quality of life of all women during midlife and beyond through an understanding of menopause and healthy aging. Its multidisciplinary membership of 2,000 leaders in the field-including clinical and basic science experts from medicine, nursing, sociology, psychology, nutrition, anthropology, epidemiology, pharmacy, and education-makes NAMS uniquely qualified to serve as the definitive resource for health professionals and the public for accurate, unbiased information about menopause and healthy aging. To learn more about NAMS, visit www.menopause.org.

Host: Prathima Setty, MD Post-menopausal patients have many options and choices for hormone therapy. But what are the issues and increased risks, if any? What are the latest updates from recent hormone therapy clinical trials and how does this impact clinical practice? Host Dr. Prathima Setty welcomes Dr. JoAnn V. Pinkerton to discuss various hormone therapy options and the latest updates in this area of concern for our patients. Dr. Pinkerton is the Director for the Midlife Division and the Midlife Health Center, a nationally recognized multidisciplinary center for women's midlife health. She serves as a member of the Board of Trustees for the North American Menopause Society and the Board of Directors for the National Women's Health Resource Center. About NAMS The interview was conducted live at The North American Menopause Society (NAMS) 2014 meeting. Founded in 1989, NAMS is North America's leading nonprofit organization dedicated to promoting the health and quality of life of all women during midlife and beyond through an understanding of menopause and healthy aging. Its multidisciplinary membership of 2,000 leaders in the field-including clinical and basic science experts from medicine, nursing, sociology, psychology, nutrition, anthropology, epidemiology, pharmacy, and education-makes NAMS uniquely qualified to serve as the definitive resource …

Host: Prathima Setty, MD Dr. Prathima Setty welcomes board certified dermatologist Dr. Dina Nicole Anderson to discuss the various cosmetic concerns of post menopausal patients, the effects of estrogent on the skin, how to counsel patients, treatment recommendations, and much more. Dr. Anderson is a board certified dermatologist in private practice in New York City. She was also the Director of Cosmetic Dermatology at SUNY Downstate in Brooklyn, NY. Dr. Anderson is a member of various academic medical societies including American Academy of Dermatology, the Women's Dermatologic Society, and the American Society of Cosmetic Dermatology & Aesthetic Surgery. About NAMS The interview was conducted live at The North American Menopause Society (NAMS) 2014 meeting. Founded in 1989, NAMS is North America's leading nonprofit organization dedicated to promoting the health and quality of life of all women during midlife and beyond through an understanding of menopause and healthy aging. Its multidisciplinary membership of 2,000 leaders in the field-including clinical and basic science experts from medicine, nursing, sociology, psychology, nutrition, anthropology, epidemiology, pharmacy, and education-makes NAMS uniquely qualified to serve as the definitive resource for health professionals and the public for accurate, unbiased information about menopause and healthy aging. To learn more about NAMS, visit

Host: Matt Birnholz, MD Guest: Michael Krychman, MD Female sexual dysfunction, or FSD, has long been under-diagnosed and under-treated in clinical practice. But in recent months, notable leaders in women's health have stepped forward to push for new recognition and prioritization of this disorder to the forefront of the FDA. On this program, host Dr. Matt Birnholz is joined by one of those leaders who helped jumpstart this critical development: Dr. Michael Krychman, Executive Director of the Southern California Center for Sexual Health in Newport Beach, CA.